Ambiq Micro (NYSE:AMBQ) Releases Earnings Results, Beats Estimates By $0.11 EPS

Ambiq Micro (NYSE:AMBQ) released its earnings results on Tuesday. The company reported ($0.41) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.52) by $0.11, Zacks reports. Ambiq Micro had a negative net margin of 50.28% and a negative return on equity of 351.35%. Ambiq Micro updated its Q2 2026 guidance to -0.290–0.230 EPS.

Here are the key takeaways from Ambiq Micro’s conference call:

• Ambiq said Q1 net sales of $25.1 million beat guidance and rose 59.3% year over year, with broad-based demand from edge AI customers and a new major customer entering production.
• Management guided Q2 net sales of $31 million to $32 million, implying about 75% year-over-year growth, and said this reflects multiple customer launch ramps and a stronger second-half outlook.
• The company highlighted business diversification, with its three largest customers contributing about 71% of Q1 sales versus 86% a year ago, while non-wearables remain about a quarter of the pipeline and are growing quickly.
• Ambiq is continuing to invest heavily in product development, with R&D up 43.3% and plans to spend roughly $85 million on operating expenses this year, which supports growth but also keeps profitability further out.
• Executives said gross margin should stay roughly flat as yield improvements and Apollo5 scaling are offset by industry-wide cost pressures, while they also acknowledged some demand may be difficult to meet due to short lead times and expediting constraints.

Ambiq Micro Price Performance

Shares of AMBQ stock traded up $14.40 on Tuesday, hitting $60.07. The stock had a trading volume of 1,461,680 shares, compared to its average volume of 365,760. The business has a 50 day moving average of $30.68 and a 200 day moving average of $29.89. The stock has a market cap of $1.28 billion and a price-to-earnings ratio of -1.52. Ambiq Micro has a 12-month low of $22.12 and a 12-month high of $63.30.

Hedge Funds Weigh In On Ambiq Micro

Institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets bought a new position in Ambiq Micro during the third quarter valued at about $28,000. New York State Common Retirement Fund bought a new position in Ambiq Micro during the fourth quarter worth about $48,000. JPMorgan Chase & Co. bought a new position in Ambiq Micro during the third quarter worth about $56,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Ambiq Micro during the third quarter worth about $65,000. Finally, Rhumbline Advisers bought a new position in Ambiq Micro during the third quarter worth about $119,000.

Analyst Ratings Changes

A number of research analysts recently issued reports on AMBQ shares. UBS Group boosted their target price on shares of Ambiq Micro from $32.00 to $43.00 and gave the company a “neutral” rating in a research report on Monday, May 4th. Wall Street Zen upgraded shares of Ambiq Micro from a “sell” rating to a “hold” rating in a research report on Sunday, February 22nd. Zacks Research upgraded shares of Ambiq Micro from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th. Northland Securities initiated coverage on shares of Ambiq Micro in a research note on Tuesday, April 21st. They set an “outperform” rating and a $44.00 price target for the company. Finally, Needham & Company LLC restated a “buy” rating on shares of Ambiq Micro in a research note on Thursday, March 5th. Three investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $43.00.

Ambiq Micro Company Profile

Ambiq Micro (NYSE: AMBQ) is a semiconductor company specializing in the design and development of ultra-low-power microcontroller units (MCUs) and application-specific integrated circuits (ASICs). The company’s core technology leverages sub-threshold voltage operation to dramatically reduce energy consumption, enabling extended battery life in a broad range of portable and always-on devices. Ambiq’s products are particularly well suited for applications where power efficiency is critical, such as wearable electronics, IoT sensors, medical monitoring equipment, and industrial automation systems.

The company’s flagship product family, the Apollo series of MCUs, offers multi-core architectures, integrated wireless connectivity options, and advanced security features.